Table 1.

Clinical Characteristics of Case/Control Pairs used in Discovery Proteomics

Patient	Age (yrs)	Race	Nodal Status	Hormone Status	Breast Cancer Side	Baseline EF (%)	Nadir EF (%)	CTRC D Timing (days)	Cardiac Medication
Case 1	48	Cauc	N1	ER+	Right	57	37	238	Enalapril, Carvedilol
Ctrl 1	40	Cauc	N1	ER+	Right	63	55		None
Case 2	46	Cauc	N3C	ER-	Right	53	42	226	Enalapril, Carvedilol
Ctrl 2A	43	Asian	N2	ER-	Left	58	53		None
Ctrl 2B	53	Cauc	N2	ER+	Left	50	45		None
Case 3	43	Asian	N0	ER-	Right	53	38	167	Lisinopril, Carvedilol
Ctrl 3	36	Cauc	N0	ER-	Left	61	52		None